ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 191 filers reported holding ASCENDIS PHARMA A/S in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,969 | +94.4% | 46,347 | +121.4% | 0.06% | +87.1% |
| Q4 2022 | $2,556 | -97.7% | 20,930 | +1816.7% | 0.03% | +3000.0% |
| Q3 2022 | $113,000 | +1.8% | 1,092 | +15.9% | 0.00% | 0.0% |
| Q1 2022 | $111,000 | +2.8% | 942 | +17.8% | 0.00% | 0.0% |
| Q4 2021 | $108,000 | -79.2% | 800 | -75.4% | 0.00% | -50.0% |
| Q3 2021 | $519,000 | +56.3% | 3,254 | +28.8% | 0.00% | 0.0% |
| Q2 2021 | $332,000 | +0.9% | 2,527 | +28.2% | 0.00% | 0.0% |
| Q4 2020 | $329,000 | +82.8% | 1,971 | +68.9% | 0.00% | +100.0% |
| Q3 2020 | $180,000 | -27.7% | 1,167 | -47.3% | 0.00% | -50.0% |
| Q1 2020 | $249,000 | -54.9% | 2,213 | -44.3% | 0.00% | -60.0% |
| Q4 2019 | $552,000 | -43.5% | 3,971 | -60.9% | 0.01% | -37.5% |
| Q3 2019 | $977,000 | -34.9% | 10,146 | -22.1% | 0.01% | -20.0% |
| Q2 2019 | $1,500,000 | +509.8% | 13,027 | +523.9% | 0.01% | +400.0% |
| Q1 2019 | $246,000 | +112.1% | 2,088 | +12.6% | 0.00% | +100.0% |
| Q4 2018 | $116,000 | -84.8% | 1,854 | -83.8% | 0.00% | -85.7% |
| Q2 2018 | $762,000 | – | 11,461 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |